risperidone has been researched along with Hemisensory Neglect in 9 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this study we directly compared the efficacy and tolerability of the atypical antipsychotics quetiapine and risperidone in elderly patients with dementia and symptoms of disturbed perception, thought content, mood or behaviour (behavioural and psychological symptoms of dementia-BPSD)." | 9.12 | Quetiapine versus risperidone in elderly patients with behavioural and psychological symptoms of dementia: efficacy, safety and cognitive function. ( Haushofer, M; Pfolz, H; Rainer, M; Struhal, C; Wick, W, 2007) |
| " We present a case of PPA in catatonic schizophrenia that was successfully treated by switching to aripiprazole from risperidone." | 7.83 | Treatment of Paroxysmal Perceptual Alteration in Catatonic Schizophrenia by Switching to Aripiprazole from Risperidone: A Case Report. ( Horiguchi, J; Ieda, M; Miyaoka, T; Nagahama, M; Tsuchie, K; Wake, R; Yamashita, S, 2016) |
| "In this study we directly compared the efficacy and tolerability of the atypical antipsychotics quetiapine and risperidone in elderly patients with dementia and symptoms of disturbed perception, thought content, mood or behaviour (behavioural and psychological symptoms of dementia-BPSD)." | 5.12 | Quetiapine versus risperidone in elderly patients with behavioural and psychological symptoms of dementia: efficacy, safety and cognitive function. ( Haushofer, M; Pfolz, H; Rainer, M; Struhal, C; Wick, W, 2007) |
| " We present a case of PPA in catatonic schizophrenia that was successfully treated by switching to aripiprazole from risperidone." | 3.83 | Treatment of Paroxysmal Perceptual Alteration in Catatonic Schizophrenia by Switching to Aripiprazole from Risperidone: A Case Report. ( Horiguchi, J; Ieda, M; Miyaoka, T; Nagahama, M; Tsuchie, K; Wake, R; Yamashita, S, 2016) |
| "This report shows symptomatic recurrences persisting more than 8 months." | 1.33 | Hallucinogen persisting perception disorder after psilocybin consumption: a case study. ( Abadie, P; Dollfus, S; Espiard, ML; Halbecq, I; Lecardeur, L, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamashita, S | 1 |
| Miyaoka, T | 1 |
| Nagahama, M | 1 |
| Ieda, M | 1 |
| Tsuchie, K | 1 |
| Wake, R | 1 |
| Horiguchi, J | 1 |
| Bozkurt, H | 1 |
| Ayaydın, H | 1 |
| Adak, İ | 1 |
| Zoroğlu, SS | 1 |
| Bellgrove, MA | 1 |
| Vance, A | 1 |
| Bradshaw, JL | 1 |
| Espiard, ML | 1 |
| Lecardeur, L | 1 |
| Abadie, P | 1 |
| Halbecq, I | 1 |
| Dollfus, S | 1 |
| Cellard, C | 1 |
| Tremblay, S | 1 |
| Lehoux, C | 1 |
| Roy, MA | 1 |
| Rainer, M | 1 |
| Haushofer, M | 1 |
| Pfolz, H | 1 |
| Struhal, C | 1 |
| Wick, W | 1 |
| Kopala, LC | 1 |
| Lewine, R | 1 |
| Good, KP | 1 |
| Fluker, M | 1 |
| Martzke, JS | 1 |
| Lapointe, JS | 1 |
| Honer, WG | 1 |
| Alcántara, AG | 1 |
| Lerner, AG | 1 |
| Shufman, E | 1 |
| Kodesh, A | 1 |
| Rudinski, D | 1 |
| Kretzmer, G | 1 |
| Sigal, M | 1 |
1 trial available for risperidone and Hemisensory Neglect
| Article | Year |
|---|---|
Quetiapine versus risperidone in elderly patients with behavioural and psychological symptoms of dementia: efficacy, safety and cognitive function.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Dementia; Dibenzothiazepines; Female; Humans; Male; M | 2007 |
8 other studies available for risperidone and Hemisensory Neglect
| Article | Year |
|---|---|
Treatment of Paroxysmal Perceptual Alteration in Catatonic Schizophrenia by Switching to Aripiprazole from Risperidone: A Case Report.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Drug Substitution; Humans; Male; Perceptual Disorders; Qu | 2016 |
Risperidone-induced paroxysmal perceptual alteration in a child with autism.
Topics: Antipsychotic Agents; Autistic Disorder; Child; Hallucinations; Humans; Male; Perceptual Disorders; | 2012 |
Local-global processing in early-onset schizophrenia: evidence for an impairment in shifting the spatial scale of attention.
Topics: Adolescent; Affect; Antipsychotic Agents; Attention; Benzodiazepines; Clopenthixol; Diazepam; Female | 2003 |
Hallucinogen persisting perception disorder after psilocybin consumption: a case study.
Topics: Adolescent; Antidepressive Agents; Antipsychotic Agents; Anxiety; Depressive Disorder; Diagnosis, Di | 2005 |
Processing spatial-temporal information in recent-onset schizophrenia: the study of short-term memory and its susceptibility to distraction.
Topics: Adult; Antipsychotic Agents; Attention; Diagnostic and Statistical Manual of Mental Disorders; Femal | 2007 |
Clinical features of schizophrenia in a woman with hyperandrogenism.
Topics: Adult; Antipsychotic Agents; Brain; Estrogens; Female; Humans; Hyperandrogenism; Perceptual Disorder | 1997 |
Is there a role for the alpha2 antagonism in the exacerbation of hallucinogen-persisting perception disorder with risperidone?
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Antipsychotic Agents; Hallucinations; Humans; Perc | 1998 |
Risperidone-associated, benign transient visual disturbances in schizophrenic patients with a past history of LSD abuse.
Topics: Adult; Antipsychotic Agents; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Perceptual Dis | 2002 |